Cara Therapeutics Inc (CARA)
0.4226
+0.01
(+3.35%)
USD |
NASDAQ |
Dec 20, 16:00
0.42
0.00 (0.00%)
After-Hours: 20:00
Cara Therapeutics Profit Margin (Quarterly): -488.1% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| NeuroMetrix Inc | -256.8% |
| Johnson & Johnson | 11.99% |
| Sarepta Therapeutics Inc | 7.19% |
| Corvus Pharmaceuticals Inc | -- |
| NovaBay Pharmaceuticals Inc | -49.65% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -258.4% |
| Return on Assets | -104.9% |
| Return on Invested Capital | -258.4% |
| Operating Margin (Quarterly) | -206.6% |
| Return on Net Operating Assets | -506.4% |